Compare ROL & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ROL | WAT |
|---|---|---|
| Founded | 1948 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5B | 29.3B |
| IPO Year | 1994 | 1996 |
| Metric | ROL | WAT |
|---|---|---|
| Price | $52.54 | $289.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 17 |
| Target Price | $66.10 | ★ $387.31 |
| AVG Volume (30 Days) | ★ 2.4M | 999.9K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | ★ 13.54 | 0.47 |
| EPS | 1.09 | ★ 10.76 |
| Revenue | $2,161,220,000.00 | ★ $3,165,286,000.00 |
| Revenue This Year | $10.42 | $104.66 |
| Revenue Next Year | $8.81 | $10.53 |
| P/E Ratio | $48.51 | ★ $27.93 |
| Revenue Growth | ★ 7.23 | 6.99 |
| 52 Week Low | $51.77 | $275.05 |
| 52 Week High | $66.14 | $414.15 |
| Indicator | ROL | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 26.74 | 33.08 |
| Support Level | N/A | $281.62 |
| Resistance Level | $58.38 | $308.14 |
| Average True Range (ATR) | 1.21 | 8.42 |
| MACD | -0.14 | 2.17 |
| Stochastic Oscillator | 4.13 | 25.05 |
Rollins is a global leader in route-based pest control services, with operations primarily in the United States and across North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US and Canada, with near-national coverage. It also has a portfolio of other brands, which it uses to reach customers through alternative sales channels. Residential pest and termite prevention accounts for the majority of Rollins' services, reflecting its ongoing focus on the US and Canadian markets.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.